We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$602M
AUM Growth
+$38.8M
Cap. Flow
+$32M
Cap. Flow %
5.32%
Top 10 Hldgs %
32.34%
Holding
165
New
9
Increased
72
Reduced
51
Closed
13

Top Buys

Rank Stock Value
1
JBTM
JBT Marel
JBTM
+$10.4M
2
SSB icon
SouthState Bank Corp
SSB
+$9.71M
3
OPLN
Openlane
OPLN
+$9.07M
4
TRS icon
TriMas Corp
TRS
+$5.77M
5
BELFB
Bel Fuse Inc Class B
BELFB
+$5.46M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$11.8M
2
MLR icon
Miller Industries
MLR
+$6.76M
3
VUSB icon
Vanguard Ultra-Short Bond ETF
VUSB
+$3.5M
4
ABG icon
Asbury Automotive
ABG
+$3.38M
5
ESGR
Enstar Group
ESGR
+$2.38M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.04%
2 Technology 16.52%
3 Financials 15.42%
4 Industrials 11.11%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAT icon
151
Heartbeam
BEAT
$28.4M
$115K 0.02%
50,000
– –
NKGN
152
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$28.2K ﹤0.01%
+43,088
New +$17.6K
ALKT icon
153
Alkami Technology
ALKT
$1.8B
– –
-50,286
Closed -$1.59M
ARW icon
154
Arrow Electronics
ARW
$10.9B
– –
-5,513
Closed -$732K
DINO icon
155
HF Sinclair
DINO
$15.9B
– –
-11,953
Closed -$533K
HSY icon
156
Hershey
HSY
$35.4B
– –
-4,895
Closed -$939K
IBTF
157
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
– –
-56,110
Closed -$1.31M
INSE icon
158
Inspired Entertainment
INSE
$177M
– –
-72,086
Closed -$668K
MRK icon
159
Merck
MRK
$324B
– –
-103,765
Closed -$11.8M
MSTR icon
160
Strategy Inc
MSTR
$33.5B
– –
-1,998
Closed -$337K
NVO
161
Novo Nordisk
NVO
$216B
– –
-2,267
Closed -$270K
OCSL icon
162
Oaktree Specialty Lending
OCSL
$1.03B
– –
-12,423
Closed -$203K
RWAY icon
163
Runway Growth Finance
RWAY
$227M
– –
-13,424
Closed -$138K
WSO icon
164
Watsco Inc
WSO
$14.9B
– –
-906
Closed -$445K
IBTE
165
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
– –
-64,180
Closed -$1.54M
3 4 5 6
7

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q4 2024 Portfolio in Review

As of Q4 2024, Advisory Research held 165 positions worth $602M, up 6.9% from $563M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Advisory Research deployed $32M of net new capital in Q4 2024, opening 9 new positions and adding to 72 existing holdings. Its largest new stake was Openlane: 492,011 shares worth $9.76M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Miller Industries, an estimated $6.76M trimmed.

  • Advisory Research's largest Q4 2024 buy was Openlane: 492,011 shares worth $9.76M.
  • Advisory Research added most to JBT Marel in Q4 2024, an estimated $10.4M increase.
  • Advisory Research's biggest Q4 2024 reduction was Miller Industries, cutting an estimated $6.76M.
  • Advisory Research fully exited Merck in Q4 2024, selling an estimated $11.8M.
  • Advisory Research's ten largest holdings make up 32% of its $602M portfolio in Q4 2024.
  • Advisory Research opened 9 new positions and closed 13 in Q4 2024.
  • Advisory Research's portfolio value rose 6.9% quarter-over-quarter to $602M.

Based on Advisory Research's 13F filing for Q4 2024, filed 13 Feb 2025.